MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,871,000 | +4.7% | 270,209 | +0.6% | 0.12% | +8.8% |
| Q2 2022 | $18,027,000 | -16.4% | 268,543 | +2.3% | 0.11% | +2.7% |
| Q1 2022 | $21,574,000 | -43.8% | 262,402 | +1.4% | 0.11% | -34.5% |
| Q4 2021 | $38,363,000 | -16.4% | 258,808 | -0.3% | 0.17% | -18.8% |
| Q3 2021 | $45,909,000 | +13.3% | 259,506 | +15.1% | 0.21% | +15.0% |
| Q1 2021 | $40,535,000 | -16.1% | 225,534 | +2.5% | 0.18% | -34.1% |
| Q4 2020 | $48,314,000 | +17.5% | 219,971 | -11.2% | 0.27% | +28.8% |
| Q3 2020 | $41,135,000 | +30.3% | 247,730 | -10.0% | 0.21% | +18.4% |
| Q2 2020 | $31,560,000 | +41.8% | 275,154 | -5.0% | 0.18% | +29.7% |
| Q1 2020 | $22,252,000 | -39.9% | 289,488 | +0.8% | 0.14% | -22.5% |
| Q4 2019 | $37,009,000 | – | 287,204 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |